This article briefly mentions SARS-CoV-2, but at length it discusses Ebola and others quite a bit more. This article isn't about what happened with COVID-19, but about whether we should have BL4 labs at all.
In my opinion, we absolutely should. Awful diseases like Ebola are effective at what they do, so they're great places to learn about molecular biology and genetics. It seems feasible that we can manage the risk well enough to get a net expected benefit.
In my opinion, we absolutely should. Awful diseases like Ebola are effective at what they do, so they're great places to learn about molecular biology and genetics. It seems feasible that we can manage the risk well enough to get a net expected benefit.